Literature DB >> 22641656

Biological response modifiers used in cancer biotherapy.

Masahide Kuroki1, Shingo Miyamoto, Takashi Morisaki, Fusanori Yotsumoto, Naoto Shirasu, Yoshie Taniguchi, Gen-Ichiro Soma.   

Abstract

Biotherapy is a form of treatment that uses the natural immune system to protect the body against infection, cancer, and other diseases, and can fortify the body against some side-effects of other treatments. Biotherapy employs substances called biological response modifiers (BRMs), which include vaccines, monoclonal antibodies, cytokines, and adjuvants. BRMs are used alone or in combination with each other. Several BRMs are widely accepted in the treatment of certain types of cancer, while others are being tried in research studies. Side-effects of biotherapy vary among agents and patients. However, these side-effects usually disappear after the end of treatment.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22641656

Source DB:  PubMed          Journal:  Anticancer Res        ISSN: 0250-7005            Impact factor:   2.480


  2 in total

Review 1.  Evidence-Based Review of BioBran/MGN-3 Arabinoxylan Compound as a Complementary Therapy for Conventional Cancer Treatment.

Authors:  Soo Liang Ooi; Debbie McMullen; Terry Golombick; Dipl Nut; Sok Cheon Pak
Journal:  Integr Cancer Ther       Date:  2017-10-17       Impact factor: 3.279

2.  Pharmacological Effects of Guava (Psidium guajava L.) Seed Polysaccharides: GSF3 Inhibits PC-3 Prostate Cancer Cell Growth through Immunotherapy In Vitro.

Authors:  Hsiao-Chien Lin; Jin-Yuarn Lin
Journal:  Int J Mol Sci       Date:  2021-03-31       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.